Skip to main navigation Skip to search Skip to main content

WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol- 2(3H)-one]: A novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activity

  • Julie Adams Brennan
  • , Radka Graf
  • , Steven M. Grauer
  • , Rachel L. Navarra
  • , Claudine M. Pulicicchio
  • , Zoë A. Hughes
  • , Qian Lin
  • , Caitlin Wantuch
  • , Sharon Rosenzweig-Lipson
  • , Farhana Pruthi
  • , Margaret Lai
  • , Deborah Smith
  • , Wouter Goutier
  • , Martina Van De Neut
  • , Albert J. Robichaud
  • , David Rotella
  • , Rolf W. Feenstra
  • , Chris Kruse
  • , Pierre Broqua
  • , Chad E. Beyer
    • Andrew C. McCreary, Mark H. Pausch, Karen L. Marquis

Research output: Contribution to journal › Article › peer-review

13   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol- 2(3H)-one]: A novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activity'. Together they form a unique fingerprint.
Sort by

Keyphrases

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science